Alpa Laboratories Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.
ALPA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alpa Laboratories Limited has submitted its financial results for the period ended December 31, 2025 to the NSE. This is a routine regulatory filing covering the third quarter / nine months of FY2025-26. No specific revenue, profit, or margin figures were disclosed in the announcement itself. Investors will need to refer to the detailed financial result document for actual numbers. The company, a pharmaceutical manufacturer, continues to meet its listing obligation by timely submission of quarterly results.
This is a procedural compliance filing with no direct stock price implication. Shareholders should review the detailed results for any material movement in revenue, margins, or bottom-line performance versus prior periods.